Regulatory Affairs

With registration experience in US/EU and China, FMD can provide regulatory strategy consultation services as well as document preparation and submission for IND and NDA. Our dedicated RA team possess hands-on experience and solid tracking record in chemical compounds, biological products and medical devices. In addition, intrinsic knowledge of the changing regulatory environment in China and close relationships with regulatory agencies and government labs are our competitive advantage.
Latest News
Fountain Medical and ProteLight Receive ChinaBio®s "Most Promising" Award

At the 4th ChinaBio® Investor Forum, held in Beijing on December 11 and 12, 2008, two companies received the prestigious "Most Promising Company" award. Selected by a panel of venture capitalists actively investing in the China biotech industry, Fountain Medical Development Ltd. won the award in the services category, and ProteLight Pharmaceutical & Biotechnology Co., Ltd won the drug development category.

Come see us at IBC pharmaceutical R&D summit, Shanghai, China, April 7-9, 2009.

Fountain will be displaying at China 2009 R&D summit. IBCLifeSciences.com

Dr. Dan Zhang will be leading the session on clinical development and outsourcing.

USA
Joanne Jiang, Ph.D., MBA
Fountain Medical Development
Tel: 732-447-6898
Email:joanne.jiang@fountain-med.com

BEIJING(China)
Phone: 86-10-8440-6940
SHANGHAI(China)
Phone:86-21-51088628
TIANJIN(China)
Phone: 86-22-25327420